(NYSE: AVNT) Avient's forecast annual revenue growth rate of 2.99% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 6.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.54%.
Avient's revenue in 2025 is $3,254,800,000.On average, 11 Wall Street analysts forecast AVNT's revenue for 2025 to be $306,203,196,615, with the lowest AVNT revenue forecast at $291,007,462,493, and the highest AVNT revenue forecast at $321,032,768,469. On average, 11 Wall Street analysts forecast AVNT's revenue for 2026 to be $315,998,037,284, with the lowest AVNT revenue forecast at $296,042,193,678, and the highest AVNT revenue forecast at $334,031,528,983.
In 2027, AVNT is forecast to generate $325,884,418,520 in revenue, with the lowest revenue forecast at $306,386,277,749 and the highest revenue forecast at $342,087,098,879.